Screening methods and early diagnosis of pancreatic cancer [Métodos de cribado y diagnóstico precoz del cáncer de páncreas]
DOI:
https://doi.org/10.62574/xjf96179Keywords:
pancreatic neoplasms, neoplasms, carcinoma islet cellAbstract
Objective: to analyze the methods of screening and early diagnosis of pancreatic cancer. Method: systematic review of 15 scientific articles. Results and Conclusion: Early diagnosis of pancreatic cancer is crucial for improving patient prognosis and survival. Among the most promising methods are tumor biomarkers such as carbohydrate antigen 19-9 (CA19-9) which, although limited by its low specificity and sensitivity, may be more effective when combined with other inflammatory markers. Endoscopic ultrasound with fine needle aspiration (EUS-FNA) is an invasive technique used to obtain tissue samples, the optimization of which is essential to increase its diagnostic efficacy.
Downloads
References
Pardanani A, Harrison C, Cortes JE, et al. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial. JAMA Oncol. 2015;1(5):643-651. doi:10.1001/jamaoncol.2015.1590
Shi J, Liu J, Tu X, et al. Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy. J Immunother Cancer. 2022;10(1):e003133. doi:10.1136/jitc-2021-003133
Fahrmann JF, Schmidt CM, Mao X, et al. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Gastroenterology. 2021;160(4):1373-1383.e6. doi:10.1053/j.gastro.2020.11.052
McBride G. Screening methods may offer early diagnosis of pancreatic cancer. J Natl Cancer Inst. 2004;96(21):1571. doi:10.1093/jnci/96.21.1571
Saito T, Nakai Y, Mizuno S, et al. A randomized-controlled trial of early endotherapy versus wait-and-see policy for mild symptomatic pancreatic stones in chronic pancreatitis. Eur J Gastroenterol Hepatol. 2019;31(8):979-984. doi:10.1097/MEG.0000000000001457
Carr RA, Roch AM, Zhong X, et al. Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma. J Gastrointest Surg. 2017;21(10):1658-1665. doi:10.1007/s11605-017-3513-z
Smits FJ, Henry AC, van Eijck CH, et al. Care after pancreatic resection according to an algorithm for early detection and minimally invasive management of pancreatic fistula versus current practice (PORSCH-trial): design and rationale of a nationwide stepped-wedge cluster-randomized trial. Trials. 2020;21(1):389. Published 2020 May 7. doi:10.1186/s13063-020-4167-9
Gu Y, Hua Q, Li Z, et al. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer. BMC Cancer. 2023;23(1):227. Published 2023 Mar 10. doi:10.1186/s12885-023-10653-4
Kulemann B, Pitman MB, Liss AS, et al. Circulating tumor cells found in patients with localized and advanced pancreatic cancer. Pancreas. 2015;44(4):547-550. doi:10.1097/MPA.0000000000000324
Dobosz Ł, Stefaniak T, Dobrzycka M, et al. Invasive treatment of pain associated with pancreatic cancer on different levels of WHO analgesic ladder. BMC Surg. 2016;16:20. Published 2016 Apr 18. doi:10.1186/s12893-016-0136-3
Liu C, Reger M, Fan H, Wang J, Zhang J. Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer. 2025;132(3):266-275. doi:10.1038/s41416-024-02929-8
Navaneethan U, Spencer C, Zhu X, Vargo JJ, Grove D, Dweik RA. Volatile organic compounds in bile can distinguish pancreatic cancer from chronic pancreatitis: a prospective observational study. Endoscopy. 2021;53(7):732-736. doi:10.1055/a-1255-9169
Mohamadnejad M, Mullady D, Early DS, et al. Increasing Number of Passes Beyond 4 Does Not Increase Sensitivity of Detection of Pancreatic Malignancy by Endoscopic Ultrasound-Guided Fine-Needle Aspiration. Clin Gastroenterol Hepatol. 2017;15(7):1071-1078.e2. doi:10.1016/j.cgh.2016.12.018
Kruger D, Yako YY, Devar J, Lahoud N, Smith M. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy. PLoS One. 2019;14(8):e0221169. Published 2019 Aug 15. doi:10.1371/journal.pone.0221169
Canivet C, Gourgou-Bourgade S, Napoléon B, et al. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort. BMC Cancer. 2018;18(1):986. Published 2018 Oct 16. doi:10.1186/s12885-018-4906-4
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Copyright (c) 2024 By the authors. This article is open access and distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) licence (https://creativecommons.org/licenses/by-nc-sa/4.0/).
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
